Allied Biotech Corp(TW:1780)
NT$23.700.00 (0.00%)
TW:1780
Allied Biotech Corp financials statements
NT$23.70
At close:0.00 (0.00%)
Allied Biotech Corp (1780) Income Statement
Allied Biotech Corp Income Statement
Last quarter (Q2 2026), Allied Biotech Corp's total revenue was NT$498.40M, an increase of 16.48% from the same quarter last year. In Q2, Allied Biotech Corp's net income was NT$67.38M. See Allied Biotech Corp’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| NT$ 849.51M | NT$ 806.92M | NT$ 720.43M | NT$ 716.75M | NT$ 676.76M | |
| NT$ 308.61M | NT$ 258.38M | NT$ 246.44M | NT$ 271.05M | NT$ 258.05M | |
| NT$ 188.22M | NT$ 170.27M | NT$ 157.72M | NT$ 171.27M | NT$ 146.38M | |
| Depreciation and Amortization | NT$ 61.00M | NT$ 61.94M | NT$ 69.45M | NT$ 71.76M | NT$ 65.24M |
| NT$ 242.44M | NT$ 205.93M | NT$ 204.79M | NT$ 270.55M | NT$ 94.06M | |
| NT$ 120.39M | NT$ 88.11M | NT$ 88.71M | NT$ 101.78M | NT$ 28.82M | |
| NT$ 43.73M | NT$ 41.92M | NT$ 33.67M | NT$ -13.76M | NT$ -94.09M | |
| NT$ 164.12M | NT$ 130.03M | NT$ 122.38M | NT$ 185.03M | NT$ 17.58M | |
| NT$ 129.46M | NT$ 100.94M | NT$ 97.41M | NT$ 146.74M | NT$ 13.04M | |
| Per Share Metrics | |||||
| Basic EPS | NT$ 1.34 | NT$ 1.05 | NT$ 1.02 | NT$ 1.54 | NT$ 0.14 |
| Diluted EPS | NT$ 1.34 | NT$ 1.05 | NT$ 1.01 | NT$ 1.53 | NT$ 0.14 |
| Weighted Average Shares Outstanding | 96.80M | 96.33M | 95.73M | 95.38M | 95.33M |
| Weighted Average Shares Outstanding (Diluted) | 96.80M | 96.33M | 95.97M | 95.78M | 95.37M |
Currency in TWD

